
The pharmaceutical industry has a corporate social responsibility (CSR) towards HIV/AIDS. Measures taken to increase awareness of HIV/AIDS, availability and accessibility of potent and patient-friendly FDCs / Kits for adults and children will go a long way in increasing awareness and acceptance of this disease and its therapy. This will improve adherence, lower resistance and facilitate better disease management. This article discusses some of the CSR initiatives and their scope.
Dosage Forms, Acquired Immunodeficiency Syndrome, Social Responsibility, Drug Industry, Anti-HIV Agents, Chemistry, Pharmaceutical, Drug Costs, Health Services Accessibility, Drug Combinations, Humans, Patient Compliance, Developing Countries
Dosage Forms, Acquired Immunodeficiency Syndrome, Social Responsibility, Drug Industry, Anti-HIV Agents, Chemistry, Pharmaceutical, Drug Costs, Health Services Accessibility, Drug Combinations, Humans, Patient Compliance, Developing Countries
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
